Table 1.
Subject characteristics.
| Subject | Age(years) | Sex | FEV1(% predicted) | FEV1/FVC(%) | Treatment |
|---|---|---|---|---|---|
| 1 | 61 | M | 80.5 | 54.2 | S |
| 2 | 29 | M | 100.5 | 79.7 | S |
| 3 | 63 | M | 83.1 | 62.5 | S, B (400) |
| 4 | 35 | M | 80.8 | 71.7 | S |
| 5 | 61 | M | 100.4 | 79.8 | S |
| 6 | 47 | F | 97.2 | 73.2 | S |
| 7 | 64 | F | 92.3 | 70.9 | S, B (800) |
| 8 | 57 | M | 89.0 | 70.2 | S |
| 9 | 66 | M | 76.9 | 53.6 | S, B (400) |
| 10 | 41 | F | 71.8 | 72.0 | S, B (400) |
| 11 | 68 | M | 54.9 | 54.2 | S, B (800) |
| Mean | 54 | 84.3 | 67.5 | ||
| 95% CI | 45, 63 | 75.1, 93.5 | 60.9, 74.0 |
Be (mg) = beclomethasone dipropionate via metered dose inhaler (daily inhaled dose); S = salbutamol via metered dose inhaler on demand.